A direct-to-consumer DNA test to help identify super-rare disease patients
Probably Genetic’s builds highly specific and efficient patient recruiting pipelines for biotech companies by identifying patients with super-rare diseases.
Lukas Lange is an expert in genomics and the CEO of Probably Genetic, which he founded in 2019. Lukas holds a PhD from the University of Oxford, while Harley specializes in big data and machine learning, holding a PhD from the University of Cambridge.
Biotech firms face complexity in treating rare genetic conditions as patient identification is difficult; only 5% of such diseases have FDA-approved medication.
Probably Genetic combines genetic science and a sophisticated toolkit of NLP-assisted online marketing methods to find and assess potential rare disease patients. Clinical-grade, fast and affordable DNA tests help identify the right patients, who can then be referred to clinical studies. This benefits individuals as well the biotech companies conducting research.
Successful founders supporting new founders in a way not yet seen in European venture capital. Let us be part of your journey!